市場調査レポート
商品コード
1467588
インターベンショナルカーディオロジーと末梢血管機器市場:製品タイプ、適応症、年齢層、エンドユーザー、地域別、2024~2032年Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
インターベンショナルカーディオロジーと末梢血管機器市場:製品タイプ、適応症、年齢層、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界のインターベンショナルカーディオロジーと末梢血管機器市場規模は、2023年に250億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて7.07%の成長率(CAGR)を示し、2032年までに470億米ドルに達すると予測しています。慢性的な心臓疾患に罹患する人の増加、末梢動脈疾患(PAD)の急増、低侵襲(MI)手技に対する消費者の嗜好の高まりは、市場を牽引する重要な要因の一つです。
インターベンショナルカーディオロジー(Interventional Cardiology)とは、多数の弁膜症、冠動脈、先天性心疾患を治療するために、透視を用いた血管内カテーテル別の手技に依存する循環器学の下位専門セグメントを指します。一方,末梢血管装置は,特に末梢血管系における動脈の閉塞や血管の狭窄を治療するために使用される医療機器であり,その結果,さまざまな身体部位への血流が減少します。これらのインターベンショナル法は、循環系に影響を及ぼす心臓病や末梢血管障害を管理し、合併症や傷跡を避け、痛みを最小限に抑え、回復を早めるために一般的に用いられています。その結果、インターベンショナルカーディオロジーと末梢血管装置は、様々な構造的心臓疾患や動脈関連疾患の治療、末梢血管内治療や冠動脈処置に幅広く応用されています。
冠動脈疾患(CAD)などの慢性的な心臓疾患を患う人の増加により、致命的な結果を防ぐための早期発見と介入の必要性が高まっています。このことは、末梢動脈疾患(PAD)の罹患率の上昇と相まって、市場成長を促進する主要要因となっています。さらに、従来の手術から低侵襲(MI)手術への移行が患者や医療専門家の間でかなり進んでいます。低侵襲手術は、切開創が小さく、手術による痛み、損傷、傷跡が少なく、入院期間が短く、精度が高く、回復が早いからです。これに伴い、高齢者人口の拡大が世界の心臓・血管疾患の負担増に寄与しており、これが製品需要を増大させています。さらに、急速な技術進歩により、主要メーカーは、より良い治療結果を得るために、インターベンショナルカーディオロジーと末梢血管機器の新しく革新的なバリエーションを開発しています。これとともに、主要メーカーによる継続的な製品の上市と製品認可数の増加が市場の成長を後押ししています。その他の要因としては、生体吸収性ステントの採用、救急・重症患者数の増加、有利な償還政策、医療インフラの改善、継続的な研究開発(R&D)活動なども市場成長を後押ししています。
The global interventional cardiology and peripheral vascular devices market size reached US$ 25.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, indication, age group, and end user.
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Accessories
Angioplasty Balloons
Angioplasty Stents
Angioplasty Catheters
Endovascular Aneurysm Repair Stent Grafts
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the product type. This includes inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts. According to the report, angioplasty balloons represented the largest segment.
Coronary Intervention
Peripheral Arterial Disease
A detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the indication has also been provided in the report. This includes coronary intervention and peripheral arterial disease.
Geriatric
Adults
Paediatric
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the age group. This includes geriatric, adults, and paediatric. According to the report, geriatric represented the largest segment.
Hospitals
Ambulatory Surgical Centers
Others
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.